HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincent Favaudon Selected Research

RPR 130401

1/2002The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincent Favaudon Research Topics

Disease

14Neoplasms (Cancer)
03/2022 - 01/2002
3Breast Neoplasms (Breast Cancer)
04/2010 - 05/2007
2Hypoxia (Hypoxemia)
04/2008 - 05/2007
2Genomic Instability
02/2008 - 06/2005
1Hyperthermia
10/2020
1Lymphoma (Lymphomas)
03/2020
1Lethargy
03/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019
1Mucositis
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Adenocarcinoma
01/2016
1Liver Neoplasms (Liver Cancer)
08/2014
1Hepatocellular Carcinoma (Hepatoma)
08/2014
1Fibrosis (Cirrhosis)
07/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
04/2010
1Prostatic Neoplasms (Prostate Cancer)
03/2010
1Glioblastoma (Glioblastoma Multiforme)
01/2010
1Inborn Genetic Diseases (Disease, Hereditary)
02/2008
1Chromosome Aberrations (Chromosome Abnormalities)
02/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2008
1Carcinoma (Carcinomatosis)
12/2005
1Hypersensitivity (Allergy)
10/2005

Drug/Important Bio-Agent (IBA)

3Biological ProductsIBA
03/2022 - 12/2005
3Protons (Proton)IBA
03/2020 - 11/2011
3Radiation-Sensitizing AgentsIBA
01/2016 - 04/2007
2Phosphotransferases (Kinase)IBA
01/2016 - 10/2005
2Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2014 - 03/2006
2DNA (Deoxyribonucleic Acid)IBA
11/2011 - 06/2005
2Estrogens (Estrogen)FDA Link
04/2008 - 05/2007
1Oxygen (Dioxygen)IBA
12/2020
1BismuthIBA
10/2020
1Vaccine AdjuvantsIBA
10/2020
1Photosensitizing Agents (Photosensitizers)IBA
10/2020
1TitaniumIBA
10/2020
1Pharmaceutical PreparationsIBA
10/2020
1Temazepam (Nocturne)FDA LinkGeneric
01/2019
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1AfatinibIBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
01/2016
1CarbonIBA
09/2014
1veliparibIBA
08/2014
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2014
1Protein Kinases (Protein Kinase)IBA
04/2010
1bicalutamide (Casodex)FDA LinkGeneric
03/2010
1AndrogensIBA
03/2010
1Histones (Histone)IBA
01/2010
1Bromodeoxyuridine (BrdU)IBA
01/2010
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
04/2008
1CCAAT-Enhancer-Binding Protein-alphaIBA
04/2008
1RNA Polymerase II (RNA Polymerase B)IBA
04/2008
1Messenger RNA (mRNA)IBA
04/2008
1Transcription Factors (Transcription Factor)IBA
04/2008
1ElementsIBA
04/2008
1Imatinib Mesylate (Gleevec)FDA Link
02/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2008
1Estrogen Receptor alphaIBA
05/2007
1Estrogen ReceptorsIBA
05/2007
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2007
11- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA
04/2007
1WortmanninIBA
10/2005
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
06/2005
1Lamin Type B (Lamin B)IBA
01/2002
1TransferasesIBA
01/2002
1RPR 130401IBA
01/2002

Therapy/Procedure

10Radiotherapy
09/2021 - 03/2006
1Immunotherapy
10/2020
1Precision Medicine
10/2020
1Hair Removal (Depilation)
01/2019
1Therapeutics
09/2014
1Chemoradiotherapy
12/2005